Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a multi-cohort, randomized, open, multicenter Phase II study to evaluate the efficacy and safety of AL2846 capsules in patients with advanced lung cancer and ovarian cancer. Objective response rate (ORR) and progression-free survival (PFS) are the primary endpoints.
Epistemonikos ID: c41a9169f4b341e4caddbbbc8047f3c585c66114
First added on: Feb 19, 2024